Moelis & Co Appoints Thorold Barker to Board

By Hao Liu • Tuesday, July 01 15:27 • Permanent Link

Moelis & Company (NYSE: MC) has announced the appointment of Thorold Barker to its Board of Directors, effective July 1, 2025. With over 30 years of experience spanning journalism, finance, and geopolitics, Mr. Barker's appointment brings a unique perspective to the board.

Ken Moelis, Chairman and CEO of Moelis & Company, expressed his delight in welcoming Mr. Barker, emphasizing the value of his global experience across business, media, and policy. Mr. Barker's extensive career includes serving as The Wall Street Journal’s Editor for Europe, Middle East and Africa, overseeing global events such as the CEO Council, and holding roles at the Financial Times and Bain & Company.

As an Independent Director, Mr. Barker joins Moelis’s Board, serving alongside Dr. Louise Mirrer, Kenneth Shropshire, and Laila Worrell. Currently a Senior Adviser at AlixPartners, a visiting fellow at the University of Oxford, and a board member of Tiger21, Mr. Barker's appointment adds further depth to the company's leadership.

Moelis & Company is a leading global independent investment bank, providing strategic advice and solutions to a diverse client base, including corporations, governments, and financial sponsors. The firm's comprehensive integrated financial advisory services cover mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. Moelis serves clients across North and South America, Europe, the Middle East, and Asia-Pacific.

For further information about Moelis & Company, visit: www.moelis.com. Following these announcements, the company's shares moved 3.16%, and are now trading at a price of $64.29. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.